Role of host defense merchanisms in the antitumor activity of adriamycin and daunomycin in mice.
D000818:Animals; D003606:Dacarbazine / Q000494:pharmacology; D003630:Daunorubicin / Q000494:pharmacology*; D004317:Doxorubicin / Q000494:pharmacology*; D006801:Humans; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000494:pharmacology; D007939:Leukemia L1210 / Q000188:drug therapy / Q000276:immunology; D007942:Leukemia, Experimental / Q000188:drug therapy / Q000276:immunology; D008223:Lymphoma / Q000188:drug therapy / Q000276:immunology; D008264:Macrophages / Q000276:immunology; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008811:Mice, Inbred DBA; D009374:Neoplasms, Experimental / Q000188:drug therapy / Q000276:immunology*
D007166:Immunosuppressive Agents; D003606:Dacarbazine; D004317:Doxorubicin; D003630:Daunorubicin